Acyloxyacyl Hydrolase Prevents Colitis and Colitis-Associated Colorectal Cancer by Inactivating Stimulatory LPS in...

Area of Science:

• Gastroenterology
• Immunology
• Microbiology

Background:

• Ulcerative colitis (UC) pathogenesis involves dysregulated immune responses to gut microbiota.
• Gram-negative bacterial lipopolysaccharides (LPS) are key inflammatory triggers.
• Acyloxyacyl hydrolase (AOAH) is a host lipase that inactivates LPS.

Purpose of the Study:

• To investigate the protective role of intestinal AOAH in preventing colitis and associated colorectal cancer.
• To determine if AOAH's function in reducing LPS levels impacts colitis development.

Main Methods:

• Utilized the dextran sodium sulfate (DSS) mouse model to induce colitis.
• Assessed the impact of AOAH activity on colonic inflammation, tissue injury, and barrier permeability.
• Manipulated intestinal LPS abundance to observe effects on colitis severity.

Main Results:

• AOAH demonstrated a protective effect against colitis, reducing inflammation, tissue injury, and barrier permeability.
• Altering intestinal LPS levels directly correlated with colitis severity, with higher LPS exacerbating and lower LPS alleviating the condition.
• AOAH also mitigated colitis-associated colorectal cancer development in the mouse model.

Conclusions:

• Intestinal AOAH plays a significant protective role in preventing colitis and colorectal cancer.
• AOAH likely prevents colitis by reducing stimulatory intestinal LPS levels, thereby protecting epithelial cell mitochondria and barrier function.
• AOAH represents a potential therapeutic target for inflammatory bowel diseases and associated cancers.